Jian Xie, President and Chief Operating Officer of Fulgent Genetics, Inc. (NASDAQ:FLGT), filed a statement of changes in beneficial ownership on October 28, 2026, reporting a share withholding transaction dated October 26, 2026.

Key Highlights

  • Reporting person: Jian Xie, President and Chief Operating Officer of Fulgent Genetics, Inc.
  • Transaction: 4,361 shares of common stock were withheld (transaction code F) on October 26, 2026, at a price of $20.22 per share, to satisfy tax withholding obligations upon vesting of restricted stock units.
  • Direct ownership after transaction: 355,563 shares of common stock held directly.
  • Indirect ownership: 220,816 shares held indirectly through The Hsieh Family Dynasty Trust, dated January 27, 2010.
  • RSU origin: The vesting relates to restricted stock units originally assumed pursuant to an Agreement and Plan of Merger dated November 7, 2022, and first reported on November 9, 2022.
  • Trust disclaimer: Xie disclaims any beneficial interest in the trust shares except with respect to any pecuniary interest therein, according to the filing.

Share Withholding Details for Fulgent Genetics President and COO

According to the filing, 4,361 shares of Fulgent Genetics common stock were withheld from Jian Xie on October 26, 2026, at a price of $20.22 per share. The filing states that the withholding was made to satisfy tax obligations arising from the vesting of certain restricted stock units. Those units were originally assumed under the Agreement and Plan of Merger dated November 7, 2022, among Fulgent Genetics, Inc., FG Merger Sub, Inc., Fulgent Pharma Holdings, Inc., and the stockholders listed in that agreement.

Fulgent Genetics is a genomic testing company. Following the reported transaction, Xie directly holds 355,563 shares of common stock, the filing discloses. An additional 220,816 shares are held indirectly through The Hsieh Family Dynasty Trust, dated January 27, 2010, on which Xie serves on the investment committee. The filing notes that Xie disclaims beneficial interest in the trust shares except to the extent of any pecuniary interest. The filing was signed by Paul Kim as attorney-in-fact on October 28, 2026.

What Was Disclosed

The filing reports a single tax-withholding transaction in which 4,361 shares were withheld from Xie at $20.22 each upon RSU vesting, leaving him with 355,563 shares directly and 220,816 shares indirectly through a family trust.